Gentex Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
As you might know, Gentex Corporation (NASDAQ:GNTX) last week released its latest quarterly, and things did not turn out so great for shareholders. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at US$648m, statutory earnings missed forecasts by 15%, coming in at just US$0.43 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
Taking into account the latest results, the most recent consensus for Gentex from nine analysts is for revenues of US$2.80b in 2027. If met, it would imply a modest 6.9% increase on its revenue over the past 12 months. Per-share earnings are expected to step up 18% to US$2.18. In the lead-up to this report, the analysts had been modelling revenues of US$2.81b and earnings per share (EPS) of US$2.25 in 2027. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a small dip in their earnings per share forecasts.
View our latest analysis for Gentex
The average price target fell 6.9% to US$25.39, with reduced earnings forecasts clearly tied to a lower valuation estimate. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Gentex, with the most bullish analyst valuing it at US$42.00 and the most bearish at US$20.00 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Gentex's revenue growth is expected to slow, with the forecast 5.5% annualised growth rate until the end of 2027 being well below the historical 8.6% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 7.3% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Gentex.
The Bottom Line
The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Gentex. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Gentex's revenue is expected to perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Gentex's future valuation.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Gentex going out to 2028, and you can see them free on our platform here.
You can also see our analysis of Gentex's Board and CEO remuneration and experience, and whether company insiders have been buying stock.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.